Replies to post #3806 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

The stockholders' questions seemed much more interesting than the typical analysts' questions on conference calls.

There’s a good reason for this: on the whole, we know more about MNTA’s business than they do :- )

Please feel free to elaborate on the interesting questions that were posed today. Regards, Dew